M. Adimy, A. Chekroun, and T. M. Touaoula, , p.885

, Difference Model Of Hematopoietic Stem Cell Dynamics, Discret And Continuous Dynamical Systems Series B, pp.2765-2791, 2015.

M. Adimy, F. Crauste, and A. Abdllaoui, DISCRETE-MATURITY STRUCTURED MODEL OF CELL DIFFERENTIATION WITH APPLICATIONS TO ACUTE MYELOGENOUS LEUKEMIA, Journal of Biological Systems, vol.92, issue.03, pp.395-424, 2008.
DOI : 10.1046/j.1365-2141.1999.01168.x
URL : https://hal.archives-ouvertes.fr/hal-00750276

J. A. , Aguirre-Ghiso, Models, mechanisms and clinical evidence for cancer dormancy, Nature Reviews Cancer, vol.7, issue.11, pp.834-846, 2007.

J. A. Aguirre-ghiso, The Problem of Cancer Dormancy: Understanding the Basic Mechanisms and Identifying Therapeutic Opportunities, Cell Cycle, vol.5, issue.16, pp.1740-1743, 2006.
DOI : 10.4161/cc.5.16.3165

H. Ahsen, S. I. Ozbay, and . Niculescu, Analysis of deterministic cyclic gene regulatory network models with delays, p.895, 2015.
DOI : 10.1007/978-3-319-15606-4
URL : https://hal.archives-ouvertes.fr/hal-01284723

M. G. Al-asadi, G. Brindle, M. Castellanos, S. T. May, K. I. Mills et al., A molecular signature of dormancy in CD34+ CD38-acute myeloid leukaemia cells, p.8111405, 2017.

B. Alberts, D. Bray, K. Hopkin, A. Johnson, J. Lewis et al., Essential Cell Biology, p.865, 2013.

J. L. Avila, A coupled model for healthy and cancerous cells dynamics in Acute Myeloid Leukemia, IFAC Proceedings Volumes 47, pp.7529-7534, 2014.

J. L. Avila, C. Bonnet, J. Clairambault, H. Ozbay, S. I. Niculescu et al.,

M. , A new model of cell dynamics in acute myeloid leukemia involving distributed delays, IFAC TDS, pp.55-60, 2012.

J. M. Brandwein, Targeting polo-like kinase 1 in acute myeloid leukemia, Therapeutic advances in hematology, pp.80-87, 2015.
DOI : 10.1038/sj.onc.1200862

J. Bélair, M. C. Mackey, and J. M. Mahaffy, Age-structured and two-delay models for erythropoiesis, Mathematical Biosciences, vol.128, issue.1-2, pp.317-346, 1995.
DOI : 10.1016/0025-5564(94)00078-E

N. Bellomo and G. Forni, Dynamics of tumor interaction with the host immune system, Mathematical and computer modelling, pp.107-122, 1994.

S. Bernard, J. Bélair, and M. C. Mackey, Oscillations in cyclical neutropenia: new evidence based on mathematical modeling, Journal of Theoretical Biology, vol.223, issue.3, pp.283-298, 2003.
DOI : 10.1016/S0022-5193(03)00090-0

H. M. Blau, T. R. Brazelton, and J. M. Weimann, The Evolving Concept of a Stem Cell, Cell, vol.105, issue.7, pp.829-841, 2001.
DOI : 10.1016/S0092-8674(01)00409-3

J. R. Brahmer and D. M. , Immune Checkpoint Inhibitors: Making Immunotherapy a Reality for the Treatment of Lung Cancer, Cancer Immunology Research, vol.1, issue.2, pp.85-91, 2013.
DOI : 10.1158/2326-6066.CIR-13-0078

F. J. Burns and J. F. Tannock, -PHASE IN THE CELL CYCLE, Cell Proliferation, vol.8, issue.4, pp.321-334, 1970.
DOI : 10.1016/0014-4827(59)90063-1

C. L. Chaffer, I. Brueckmann, C. Scheel, A. J. Kaestli, P. A. Wiggins et al., Normal and 925 neoplastic nonstem cells can spontaneously convert to a stem-like state Proceedings of the National Academy of Sciences, pp.7950-7955, 2011.

G. M. Crane, E. Jeffery, and S. J. Morrison, Adult haematopoietic stem cell niches, Nature Reviews Immunology, vol.17, issue.9, 2017.
DOI : 10.1016/j.stemcr.2016.06.009

C. Colijn and M. C. Mackey, A mathematical model of hematopoiesis???I. Periodic chronic myelogenous leukemia, Journal of Theoretical Biology, vol.237, issue.2, pp.117-132, 2005.
DOI : 10.1016/j.jtbi.2005.03.033

F. Delhommeau, S. Dupont, V. D. Valle, C. James, S. Trannoy et al., TET2 in Myeloid Cancers, pp.3602289-3602319, 2009.

W. Djema, F. Mazenc, and C. Bonnet, Stability analysis and robustness results for a nonlinear system with distributed delays describing hematopoiesis, Systems & Control Letters, vol.102, pp.93-101, 2017.
DOI : 10.1016/j.sysconle.2017.01.007
URL : https://hal.archives-ouvertes.fr/hal-01627125

W. Djema, F. Mazenc, and C. Bonnet, Analysis of a Nonlinear Delay Differential-Difference 940

B. Model and . Ifac-papersonline, IFAC Conference on Time-Delay Systems, vol.49, issue.10, pp.246-251, 2016.

W. Djema, F. Mazenc, C. Bonnet, J. Clairambault, P. Hirsch et al., Stability of a Delay System Coupled to a Delay Differential, Difference System Describing the Coexistence of Ordinary and Mutated Hematopoietic Stem cells, the 55 th Conference on 945 Decision and Control, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01389870

W. Djema, F. Mazenc, C. Bonnet, J. Clairambault, P. Hirsch et al., Analysis of a model of dormancy in cancer as a state of coexistence between tumor and healthy stem cells, 2017 American Control Conference (ACC), 2017.
DOI : 10.23919/ACC.2017.7963751
URL : https://hal.archives-ouvertes.fr/hal-01677927

H. Döhner, D. J. Weisdorf, and C. D. Bloomfield, Acute Myeloid Leukemia, New England Journal of Medicine, vol.373, issue.12, pp.1136-1152, 2015.
DOI : 10.1056/NEJMra1406184

]. S. Ebinger, E. Z. Ozdemir, C. Ziegenhain, S. Tiedt, C. C. Alves et al., Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia, pp.30-849, 2016.

]. R. Eftimie, J. L. Bramson, and D. J. Earn, Interactions Between the Immune System and Cancer: A??Brief Review of??Non-spatial Mathematical Models, Bulletin of Mathematical Biology, vol.39, issue.5, pp.955-957, 2011.
DOI : 10.1002/eji.200839152

H. Enderling, Cancer Stem Cells and Tumor Dormancy Sys. Biol. of Tumor Dormancy, pp.55-71, 2013.

C. Pera, P. W. Peterson, and . Andrews, Stem cell states, fates, and the rules of attraction, Cell Stem Cell, vol.4, pp.960-387, 2009.

Y. Fang, L. Zhong, M. Lin, X. Zhou, H. Jing et al., MEK/ERK Dependent Activation of STAT1 Mediates Dasatinib-Induced Differentiation of Acute Myeloid Leukemia, PLoS ONE, vol.20, issue.6, p.66915, 2013.
DOI : 10.1371/journal.pone.0066915.g007

M. Feuring-buske, A. E. Frankel, R. L. Alexander, B. Gerhard, and D. E. Hogge, A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors, Cancer Research, vol.62, issue.6, pp.1730-1736, 2002.

M. Ferrarini, E. Ferrero, L. Dagna, A. Poggi, and M. R. Zocchi, Human ???? T cells: a nonredundant system in the immune-surveillance against cancer, Trends in Immunology, vol.23, issue.1, pp.14-18, 2002.
DOI : 10.1016/S1471-4906(01)02110-X

C. Foley and M. C. Mackey, Dynamic hematological disease: a review, Journal of Mathematical Biology, vol.89, issue.3, pp.285-322, 2009.
DOI : 10.1111/j.1600-0609.1986.tb02283.x

C. Foley, S. Bernard, and M. C. Mackey, Cost-effective G-CSF therapy strategies for cyclical neutropenia: Mathematical modelling based hypotheses, Journal of Theoretical Biology, vol.238, issue.4, pp.754-763, 2006.
DOI : 10.1016/j.jtbi.2005.06.021
URL : https://hal.archives-ouvertes.fr/hal-00542529

J. Folkman and R. Kalluri, Cancer without disease, Nature, vol.427, issue.6977, pp.427-786, 2004.
DOI : 10.1038/427787a

, Fridman Stability of linear descriptor systems with delay: a Lyapunov-based approach, Journal of Mathematical Analysis and Applications, vol.273, issue.1, pp.24-44, 2002.

E. Fridman, Introduction to time-delay systems: analysis and control, Birkhauser, Sys- 980 tems and Control: Foundations and Applications, 2014.
DOI : 10.1007/978-3-319-09393-2

E. Fridman, C. Bonnet, F. Mazenc, and W. Djema, Stability of the cell dynamics in acute myeloid leukemia, Systems & Control Letters, vol.88, pp.91-100, 2016.
DOI : 10.1016/j.sysconle.2015.09.006
URL : https://hal.archives-ouvertes.fr/hal-01257577

R. A. Gatenby, A change of strategy in the war on cancer, Nature, vol.5, issue.7246, pp.459-508, 2009.
DOI : 10.1038/459508a

C. D. Godwin, R. P. Gale, and R. B. Walter, Gemtuzumab ozogamicin in acute myeloid leukemia, p.985, 2017.

K. Gu and Y. Liu, Lyapunov???Krasovskii functional for uniform stability of coupled differential-functional equations, Automatica, vol.45, issue.3, pp.798-804, 2009.
DOI : 10.1016/j.automatica.2008.10.024

J. K. Hale, Sufficient conditions for stability and instability of autonomous functional-differential equations, Journal of Differential Equations, vol.1, issue.4, pp.452-482, 1965.
DOI : 10.1016/0022-0396(65)90005-7

E. C. Hayden, Cutting off cancer's supply lines, Nature, vol.285, issue.7239, pp.458686-687, 2009.
DOI : 10.1016/S1535-6108(03)00085-0

P. Hirsch, Y. Zhang, R. Tang, V. Joulin, H. Boutroux et al., Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia, Nature Communications, vol.3, p.12475, 2016.
DOI : 10.1038/cddis.2012.137
URL : https://hal.archives-ouvertes.fr/hal-01358183

]. R. Hoffman, E. J. Benz, L. E. Silberstein, H. Heslop, J. Weitz et al., Hematology: Basic Principles and Practice, p.995, 2012.

M. Hollstein, D. Sidransky, B. Vogelstein, and C. C. Harris, p53 mutations in human cancers, p53 mutations in human cancers, pp.49-53, 1991.
DOI : 10.1126/science.1905840

C. Hosing, Hematopoietic Stem Cell Mobilization with G-CSF, Methods Mol Biol, vol.904, pp.37-1000, 2012.
DOI : 10.1007/978-1-61779-943-3_3

G. Jansen, R. Gatenby, and C. A. , Aktipis, Control vs. eradication: Applying infectious disease treatment strategies to cancer, Proceedings of the National Academy of Sciences of United States of America, pp.937-938, 2015.

C. T. Jordan, M. L. Guzman, and M. Noble, Cancer stem cells, 1005.

, Medicine, vol.355, issue.12, pp.1253-1261, 2006.

I. Karafyllis, P. Pepe, and Z. P. Jiang, Stability results for systems described by coupled retarded functional differential equations and functional difference equations, Nonlinear Analysis: Theory, Methods & Applications, vol.71, issue.7-8, pp.3339-3362, 2009.
DOI : 10.1016/j.na.2009.01.244

I. Kareva, Primary and metastatic tumor dormancy as a result of population heterogeneity, Biology Direct, vol.46, issue.7, p.37, 2016.
DOI : 10.1016/j.ejca.2010.02.027

J. P. Keener and J. Sneyd, Mathematical physiology, vol.1, 2009.

V. Kolmanovskii and A. Myshkis, Introduction to the Theory and Applications of Functional Differential Equations, 1999.
DOI : 10.1007/978-94-017-1965-0

E. Lainey, S. Thépot, C. Bouteloup, M. Sébert, L. Adès et al., , p.1015

A. Botton, P. Baruchel, G. Fenaux, S. Kroemer, and . Boehrer, Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: Delineation of anti-leukemic mechanisms of action, Biochemical Pharmacology, vol.82, pp.1457-1466, 2011.

C. J. Langer, Emerging Immunotherapies in the Treatment of Nonsmall Cell Lung Cancer (NSCLC): The Role of Immune Checkpoint Inhibitors, American journal of clinical 1020 oncology, pp.422-430, 2015.

A. G. Mckendrick, Applications of Mathematics to Medical Problems, Proceedings of the Edinburgh Mathematical Society 44, pp.98-130, 1925.
DOI : 10.1038/104660a0

, Unified hypothesis of the origin of aplastic anemia and periodic hematopoiesis, Blood, vol.51, pp.941-956, 1978.

M. C. Mackey, L. Pujo-menjouet, and J. Wu, Periodic Oscillations of Blood Cell Populations in Chronic Myelogenous Leukemia, SIAM Journal on Mathematical Analysis, vol.38, issue.1, pp.166-187, 2006.
DOI : 10.1137/04061578X

M. Malisoff, F. Mazenc, U. K. Czochra, T. Stiehl, A. D. Ho et al., Modeling of asymmetric cell division in hematopoietic stem cellsregulation of self-renewal is essential for efficient repopulation, Stem cells and development, vol.18, issue.3, pp.377-386, 2009.

A. N. Michel, L. Hou, and D. Liu, Stability of Dynamical Systems: Continuous, Discontinuous , and Discrete Systems, Systems & Control: Foundations & Applications, Birkhäuser, 1035 2 nd Ed, 2015.
DOI : 10.1007/978-3-319-15275-2

D. Morgan, The Cell Cycle: Principles of Control, Primers in Biology Series, p.297, 2006.

G. N. Naumov, J. Folkman, and O. Straume, Tumor dormancy due to failure of angiogenesis: role of the microenvironment, Clinical & Experimental Metastasis, vol.10, issue.3, p.5160, 2009.
DOI : 10.1091/mbc.12.4.863

M. Nielsen, J. Thomsen, S. Primdahl, U. Dyreborg, and J. Andersen, Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies, British Journal of Cancer, vol.56, issue.6
DOI : 10.1038/bjc.1987.296

, J. Cancer, vol.56, issue.6, p.8149, 1987.

H. Ozbay, C. Bonnet, H. Benjelloun, and J. Clairambault, Stability Analysis of Cell Dynamics in Leukemia, Mathematical Modelling of Natural Phenomena, vol.213, issue.2, pp.203-234, 2012.
DOI : 10.1002/jcp.21140
URL : https://hal.archives-ouvertes.fr/hal-00766052

D. M. , The blockade of immune checkpoints in cancer immunotherapy, Nature Reviews Cancer, vol.12, issue.4, pp.1045-252, 2012.
DOI : 10.1038/nrc3237

E. Passegué, C. H. Jamieson, L. E. Ailles, and I. L. Weissman, Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?, Proc. Natl. Acad. Sci., Regenerative Medicine, pp.11842-1050, 2003.
DOI : 10.1073/pnas.2034201100

P. Pepe, The Liapunov's second method for continuous time difference equations, International Journal of Robust and Nonlinear Control, vol.39, issue.15, pp.1389-1405, 2003.
DOI : 10.1109/9.362855

P. Pepe, I. Karafyllis, and Z. P. Jiang, On the Liapunov???Krasovskii methodology for the ISS of systems described by coupled delay differential and difference equations, Automatica, vol.44, issue.9, pp.1055-1099, 2008.
DOI : 10.1016/j.automatica.2008.01.010

L. Preziosi, From population dynamics to modelling the competition between tumors and immune system, Mathematical and Computer Modelling, vol.23, issue.6, pp.135-152, 1996.
DOI : 10.1016/0895-7177(96)00023-4

E. Pronier and F. Delhommeau, Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors, Blood, vol.118, issue.9, pp.2551-2555, 2011.
DOI : 10.1182/blood-2010-12-324707

L. Pujo-menjouet, Blood Cell Dynamics: Half of a Century of Modelling, Mathematical Modelling of Natural Phenomena, vol.293, issue.2, pp.92-115, 2016.
DOI : 10.1016/j.jtbi.2011.10.017
URL : https://hal.archives-ouvertes.fr/hal-01382783

L. Pujo-menjouet, S. Bernard, and M. C. Mackey, Model of Hematopoietic Stem Cells, SIAM Journal on Applied Dynamical Systems, vol.4, issue.2, pp.312-332, 2005.
DOI : 10.1137/030600473

]. E. Pronier and F. Delhommeau, Role of TET2 Mutations in Myeloproliferative Neoplasms, Current Hematologic Malignancy Reports, vol.24, issue.20, pp.1065-57, 2012.
DOI : 10.1038/leu.2009.169

H. Qian, Cooperativity in Cellular Biochemical Processes: Noise-Enhanced Sensitivity, Fluctuating Enzyme, Bistability with Nonlinear Feedback, and Other Mechanisms for Sigmoidal Responses, Annual Review of Biophysics, vol.41, issue.1, pp.179-204, 2012.
DOI : 10.1146/annurev-biophys-050511-102240

]. T. Reya, S. J. Morrison, M. F. Clarke, and I. L. Weissman, Stem cells, cancer, and cancer stem cells, nature, pp.1070-414, 2001.

A. R. Reynolds, Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors, Nature Medicine, vol.92, issue.4, pp.392-400, 2009.
DOI : 10.1091/mbc.11.11.3873

J. M. Rowe and B. Löwenberg, Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drug, Blood, vol.121, issue.24, pp.4838-4841, 2013.
DOI : 10.1182/blood-2013-03-490482
URL : http://www.bloodjournal.org/content/bloodjournal/121/24/4838.full.pdf

C. Saygin and H. E. Carraway, Emerging therapies for acute myeloid leukemia, Journal of Hematology & Oncology, vol.2, issue.5, p.93, 2017.
DOI : 10.1038/bcj.2012.14

R. D. Schreiber, L. J. Old, and M. J. Smyth, Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion, Science, vol.144, issue.5, pp.331-1565, 2011.
DOI : 10.1016/j.cell.2011.02.013

J. A. Smith and . Martin, Do Cells Cycle?, Proceedings of the National Academy of Sciences, pp.1263-1267, 1973.
DOI : 10.1073/pnas.70.4.1263
URL : http://www.pnas.org/content/70/4/1263.full.pdf

E. Solary, O. A. Bernard, A. Tefferi, F. Fuks, and W. Vainchenker, The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases, Leukemia, vol.122, issue.3, pp.485-496, 2014.
DOI : 10.1182/blood-2013-08-518886

, Marciniak-Czochra, Characterization of stem cells using mathematical models of multistage cell lineages, Mathematical and Computer Modelling, vol.53, issue.7, pp.10851505-1517, 2011.

T. Stiehl and A. Marciniak-czochra, Mathematical Modeling of Leukemogenesis and Cancer Stem Cell Dynamics, Mathematical Modelling of Natural Phenomena, vol.12, issue.10, pp.166-202, 2012.
DOI : 10.1007/s12094-010-0574-9

R. M. Stone, S. J. Mandrekar, B. L. Sanford, K. Laumann, S. Geyer et al., Mutation, New England Journal of Medicine, vol.377, issue.5, 2017.
DOI : 10.1056/NEJMoa1614359

D. B. Sykes, Y. S. Kfoury, F. E. Mercier, M. J. Wawer, J. M. Law et al., Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia, Cell, vol.167, issue.1, pp.1095-167, 2016.
DOI : 10.1016/j.cell.2016.08.057

H. R. Thieme, Mathematics in Population Biology, Princeton Series in Theoretical and 1100 Computational Biology, 2003.

B. Tuch, Stem cells -a clinical update, Australian family physician, vol.35, issue.9, p.719, 2006.

J. W. Uhr, R. H. Scheuermann, N. E. Street, and E. S. Vitetta, Cancer dormancy: Opportunities for new therapeutic approaches, Nature Medicine, vol.343, issue.5, pp.505-509, 1997.
DOI : 10.1038/nm0196-52

M. D. Vesely, Natural innate and adaptive immunity to cancer, Annual review of immunology, pp.235-271, 2011.

G. C. Wake, The Solution and the Stability of a Nonlinear Age-Structured Population model, The ANZIAM Journal, vol.45, issue.02, pp.153-165, 2003.

G. Wang, Analysis of Complex Diseases: A Mathematical Perspective, p.1110, 2013.
DOI : 10.1201/b16259

K. P. Wilkie and P. Hahnfeldt, Tumorimmune dynamics regulated in the microenvironment inform the transient nature of immune-induced tumor dormancy, J. Cancer Research, vol.73, issue.12, p.353444, 2013.

P. P. Zarrinkar, AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML), Blood, vol.114, issue.14, pp.2984-2992, 2009.
DOI : 10.1182/blood-2009-05-222034

L. Zitvogel, A. Tesniere, and G. Kroemer, Cancer despite immunosurveillance: immunoselection and immunosubversion, Nature Reviews Immunology, vol.65, issue.Suppl. 1, pp.715-727, 2006.
DOI : 10.1158/0008-5472.CAN-04-4252

L. Zitvogel, L. Apetoh, F. Ghiringhelli, and G. Kroemer, Immunological aspects of cancer chemotherapy, Nature Reviews Immunology, vol.313, issue.1, pp.58-73, 2008.
DOI : 10.4049/jimmunol.172.4.2039